Christina Yap
Cited by
Cited by
Adaptive designs in clinical trials: why use them, and how to run and report them
P Pallmann, AW Bedding, B Choodari-Oskooei, M Dimairo, L Flight, ...
BMC medicine 16, 1-15, 2018
Transplantation of discarded livers following viability testing with normothermic machine perfusion
H Mergental, RW Laing, AJ Kirkham, MTPR Perera, YL Boteon, J Attard, ...
Nature communications 11 (1), 2939, 2020
Tolerability and clinical activity of post-transplantation azacitidine in patients allografted for acute myeloid leukemia treated on the RICAZA trial
C Craddock, N Jilani, S Siddique, C Yap, J Khan, S Nagra, J Ward, ...
Biology of Blood and Marrow Transplantation 22 (2), 385-390, 2016
Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: Investigating dose–volume relationships and role for inverse planning
LM Tho, M Glegg, J Paterson, C Yap, A MacLeod, M McCabe, ...
International Journal of Radiation Oncology* Biology* Physics 66 (2), 505-513, 2006
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide
CN Harrison, AJ Mead, A Panchal, S Fox, C Yap, E Gbandi, A Houlton, ...
Blood, The Journal of the American Society of Hematology 130 (17), 1889-1897, 2017
Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial
PN Newsome, R Fox, AL King, D Barton, NN Than, J Moore, C Corbett, ...
The Lancet Gastroenterology & Hepatology 3 (1), 25-36, 2018
Viability testing and transplantation of marginal livers (VITTAL) using normothermic machine perfusion: study protocol for an open-label, non-randomised, prospective, single …
RW Laing, H Mergental, C Yap, A Kirkham, M Whilku, D Barton, ...
BMJ open 7 (11), e017733, 2017
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design
M Dimairo, P Pallmann, J Wason, S Todd, T Jaki, SA Julious, AP Mander, ...
bmj 369, 2020
Development of clinical criteria for functional assessment to predict primary nonfunction of high‐risk livers using normothermic machine perfusion
H Mergental, BTF Stephenson, RW Laing, AJ Kirkham, DAH Neil, ...
Liver Transplantation 24 (10), 1453-1469, 2018
A comparison of short-term and long-term air pollution exposure associations with mortality in two cohorts in Scotland
IJ Beverland, GR Cohen, MR Heal, M Carder, C Yap, C Robertson, ...
Environmental health perspectives 120 (9), 1280-1285, 2012
How to design a dose-finding study using the continual reassessment method
GM Wheeler, AP Mander, A Bedding, K Brock, V Cornelius, AP Grieve, ...
BMC medical research methodology 19, 1-15, 2019
Embracing model-based designs for dose-finding trials
SB Love, S Brown, CJ Weir, C Harbron, C Yap, B Gaschler-Markefski, ...
British journal of cancer 117 (3), 332-339, 2017
Combination lenalidomide and azacitidine: a novel salvage therapy in patients who relapse after allogeneic stem-cell transplantation for acute myeloid leukemia
C Craddock, D Slade, C De Santo, R Wheat, P Ferguson, A Hodgkinson, ...
Journal of Clinical Oncology 37 (7), 580, 2019
When to keep it simple–adaptive designs are not always useful
JMS Wason, P Brocklehurst, C Yap
BMC medicine 17, 1-7, 2019
Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive …
BA Fisher, T Veenith, D Slade, C Gaskell, M Rowland, T Whitehouse, ...
The Lancet Respiratory Medicine 10 (3), 255-266, 2022
Implementation of platform trials in the COVID-19 pandemic: a rapid review
AM Vanderbeek, JM Bliss, Z Yin, C Yap
Contemporary Clinical Trials 112, 106625, 2022
Dose transition pathways: the missing link between complex dose-finding designs and simple decision-making
C Yap, LJ Billingham, YK Cheung, C Craddock, J O'Quigley
Clinical Cancer Research 23 (24), 7440-7447, 2017
REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of …
A King, D Barton, HA Beard, N Than, J Moore, C Corbett, J Thomas, ...
BMJ open 5 (3), e007700, 2015
Use of real-time PCR to measure Epstein–Barr virus genomes in whole blood
E Leung, BK Shenton, G Jackson, FK Gould, C Yap, D Talbot
Journal of immunological methods 270 (2), 259-267, 2002
Ruxolitinib versus best available therapy for polycythemia vera intolerant or resistant to hydroxycarbamide in a randomized trial
CN Harrison, J Nangalia, R Boucher, A Jackson, C Yap, J O'Sullivan, ...
Journal of Clinical Oncology 41 (19), 3534, 2023
The system can't perform the operation now. Try again later.
Articles 1–20